ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
125.07M
Enterprise Value 3
97.08M
Trailing P/E
175.33
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.56
Price/Book (mrq)
1.60
Enterprise Value/Revenue 3
1.21
Enterprise Value/EBITDA 6
-3.67

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-27.27%
S&P500 52-Week Change 325.98%
52 Week High 34.4600
52 Week Low 32.4000
50-Day Moving Average 32.6270
200-Day Moving Average 33.1965

Share Statistics

Avg Vol (3 month) 378.12k
Avg Vol (10 day) 392.38k
Shares Outstanding 547.56M
Float 35.13M
% Held by Insiders 17.67%
% Held by Institutions 169.32%
Shares Short (Dec 30, 2019) 4845.45k
Short Ratio (Dec 30, 2019) 48.33
Short % of Float (Dec 30, 2019) 42.20%
Short % of Shares Outstanding (Dec 30, 2019) 41.78%
Shares Short (prior month Nov 28, 2019) 4815.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2105:100
Last Split Date 3Oct 20, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2019
Most Recent Quarter (mrq)Oct 30, 2019

Profitability

Profit Margin 1.03%
Operating Margin (ttm)-36.72%

Management Effectiveness

Return on Assets (ttm)-16.76%
Return on Equity (ttm)1.07%

Income Statement

Revenue (ttm)80.12M
Revenue Per Share (ttm)1.69
Quarterly Revenue Growth (yoy)-5.00%
Gross Profit (ttm)23.25M
EBITDA -26.42M
Net Income Avi to Common (ttm)822k
Diluted EPS (ttm)0.0150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)56.89M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)28.9M
Total Debt/Equity (mrq)36.90
Current Ratio (mrq)3.36
Book Value Per Share (mrq)1.65

Cash Flow Statement

Operating Cash Flow (ttm)8.94M
Levered Free Cash Flow (ttm)-19.45M